Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07521358) titled 'Magnesium Supplementation With Fluoxetine for Cognitive Function in Depression' on April 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).

Primary Sponsor: Hasanuddin University

Condition: Major Depressive Disorder (MDD)

Intervention: Drug: Fluoxetine (drug)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: July 1, 2025

Target Sample Size: 40

Countries of Recruitment: Indonesia

To know more, visit https://clinicaltrials.gov/study/NCT07521358

Published by HT Digi...